Intelligent Bleeding Control Systems via Coordinated Trigeminal and Vagal Nerve Stimulation
Legal Citation
Summary of the Inventive Concept
A novel system integrating coordinated trigeminal and vagal nerve stimulation with advanced technologies like AI, IoT, and blockchain to create a more effective, personalized, and secure bleeding control solution.
Background and Problem Solved
The original patent, 'Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation', provides a foundational approach to preventing and treating bleeding. However, it lacks the ability to adapt to individual patient needs, ensure data security, and provide real-time feedback. The new inventive concept addresses these limitations by incorporating synergistic technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The intelligent bleeding control system comprises a wearable device with at least two electrodes for non-invasive electrical stimulation of the trigeminal and vagal nerves. A machine learning module predicts optimal stimulation parameters based on real-time patient data and adjusts the stimulation accordingly. The system also includes an IoT-enabled sensor module that monitors vital signs and adjusts the stimulation in real-time. Furthermore, a blockchain-based decentralized data storage module ensures secure and transparent storage of patient data and stimulation protocols. The system can transmit stimulation data to a cloud-based server for analysis and feedback, enabling personalized treatment plans.
Novelty and Inventive Step
The new claims introduce the innovative integration of AI, IoT, and blockchain technologies with coordinated trigeminal and vagal nerve stimulation, providing a novel and non-obvious solution for bleeding control. The incorporation of machine learning, IoT-enabled sensors, and blockchain-based data storage creates a more effective, adaptive, and secure system that goes beyond the original patent's capabilities.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT-enabled sensors, or alternative blockchain protocols. Additionally, the system could be adapted for use in different medical settings, such as emergency response or surgical procedures.
Potential Commercial Applications and Market
The intelligent bleeding control system has significant commercial potential in the medical device industry, particularly in the areas of emergency medicine, surgery, and wound care. The system's ability to provide personalized, real-time bleeding control solutions could revolutionize the treatment of bleeding disorders and traumatic injuries, addressing a significant unmet medical need.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering focused on non-invasive neural stimulation techniques for physiological intervention, specifically hemorrhage control and hemostasis management
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with expertise in neural stimulation, electrical medical devices, signal processing, and advanced sensor technologies, typically holding a master's or doctoral degree with 3-5 years of specialized experience
Obviousness Rationale
A PHOSITA would recognize that integrating machine learning, IoT sensors, and blockchain with existing neural stimulation techniques represents a predictable technological evolution. The source patent establishes a foundational method of coordinated nerve stimulation for bleeding control, which naturally invites augmentation through contemporary digital health technologies. The proposed variations represent logical extensions of the original patent's core methodology using well-established engineering approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,788 |
|---|---|
| Title | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| Assignee(s) | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH |